These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23066948)

  • 1. Detection of HLA-B*58:01, the susceptible allele for allopurinol-induced hypersensitivity, by loop-mediated isothermal amplification.
    Kwok J; Kwong KM
    Br J Dermatol; 2013 Mar; 168(3):526-32. PubMed ID: 23066948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loop-mediated isothermal amplification for detection of HLA-B*58:01 allele.
    Kwok J; Kwong KM
    Tissue Antigens; 2013 Feb; 81(2):83-92. PubMed ID: 23240628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
    Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
    Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-B*5801: utility and cost-effectiveness in the Asia-Pacific Region.
    Yeo SI
    Int J Rheum Dis; 2013 Jun; 16(3):254-7. PubMed ID: 23981744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response.
    Yun J; Mattsson J; Schnyder K; Fontana S; Largiadèr CR; Pichler WJ; Yerly D
    Clin Exp Allergy; 2013 Nov; 43(11):1246-55. PubMed ID: 24152157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency.
    Jung JW; Song WJ; Kim YS; Joo KW; Lee KW; Kim SH; Park HW; Chang YS; Cho SH; Min KU; Kang HR
    Nephrol Dial Transplant; 2011 Nov; 26(11):3567-72. PubMed ID: 21393610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.
    Hung SI; Chung WH; Liou LB; Chu CC; Lin M; Huang HP; Lin YL; Lan JL; Yang LC; Hong HS; Chen MJ; Lai PC; Wu MS; Chu CY; Wang KH; Chen CH; Fann CS; Wu JY; Chen YT
    Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4134-9. PubMed ID: 15743917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple and rapid detection of HLA-A*31:01 for prediction of carbamazepine-induced hypersensitivity using loop-mediated isothermal amplification method.
    Niihara H; Kohno K; Taketani T; Kaneko S; Ito T; Sugamori T; Takahashi N; Miyaoka T; Okazaki S; Yasuda H; Furuya M; Nagahama M; Morita E
    J Dermatol Sci; 2014 Apr; 74(1):88-92. PubMed ID: 24388047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness Analysis for Genotyping before Allopurinol Treatment to Prevent Severe Cutaneous Adverse Drug Reactions.
    Ke CH; Chung WH; Wen YH; Huang YB; Chuang HY; Tain YL; Wang YL; Wu CC; Hsu CN
    J Rheumatol; 2017 Jun; 44(6):835-843. PubMed ID: 28365572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of HLA-B*5801 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis.
    Yu KH; Yu CY; Fang YF
    Int J Rheum Dis; 2017 Sep; 20(9):1057-1071. PubMed ID: 28857441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study.
    Ko TM; Tsai CY; Chen SY; Chen KS; Yu KH; Chu CS; Huang CM; Wang CR; Weng CT; Yu CL; Hsieh SC; Tsai JC; Lai WT; Tsai WC; Yin GD; Ou TT; Cheng KH; Yen JH; Liou TL; Lin TH; Chen DY; Hsiao PJ; Weng MY; Chen YM; Chen CH; Liu MF; Yen HW; Lee JJ; Kuo MC; Wu CC; Hung SY; Luo SF; Yang YH; Chuang HP; Chou YC; Liao HT; Wang CW; Huang CL; Chang CS; Lee MT; Chen P; Wong CS; Chen CH; Wu JY; Chen YT; Shen CY;
    BMJ; 2015 Sep; 351():h4848. PubMed ID: 26399967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug eruptions induced by allopurinol associated with HLA-B*5801.
    Zeng M; Zhang M; Liu F; Yan W; Kong Q; Sang H
    Indian J Dermatol Venereol Leprol; 2015; 81(1):43-5. PubMed ID: 25566896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of HLA-B5801 genotyping in the treatment of gout patients with chronic renal insufficiency in Korea.
    Park DJ; Kang JH; Lee JW; Lee KE; Wen L; Kim TJ; Park YW; Park SH; Lee SS
    Arthritis Care Res (Hoboken); 2015 Feb; 67(2):280-7. PubMed ID: 25047754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leukocyte antigens and drug hypersensitivity.
    Chung WH; Hung SI; Chen YT
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid detection of HLA-A*31:01 allele in DNA and blood samples using loop-mediated isothermal amplification.
    Cheung YK; Kwok M; Chan E; Kwan P
    Br J Dermatol; 2014 Jul; 171(1):90-6. PubMed ID: 24593191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies.
    Wu R; Cheng YJ; Zhu LL; Yu L; Zhao XK; Jia M; Wen CH; Long XZ; Tang T; He AJ; Zeng YY; Ma ZF; Zheng Z; Ni MZ; Cai GJ
    Oncotarget; 2016 Dec; 7(49):81870-81879. PubMed ID: 27835909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of HLA-B*58:01 with TaqMan assay and its association with allopurinol-induced sCADR.
    Zhang X; Ma H; Hu C; Yu B; Ma W; Wu Z; Luo X; Zou H; Guan M
    Clin Chem Lab Med; 2015 Feb; 53(3):383-90. PubMed ID: 25257159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HLA-B58.01 and allopurinol hypersensitivity renal vasculitis in a Chinese patient].
    Mariette F; Scarfoglière V; Giot M; Basire A; Rouby F; Daniel L; Jourde-Chiche N
    Rev Med Interne; 2022 Jul; 43(7):436-439. PubMed ID: 35606203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B*58: 01 carrier status of Hmong in Minnesota: first in Hmong genotyping for prevalence of this biomarker of risk for severe cutaneous adverse reactions caused by allopurinol.
    Peng K; Bjork J; Wen YF; Roman YM; Culhane-Pera K; Lo MX; Gertner E; Straka RJ
    Pharmacogenet Genomics; 2020 Feb; 30(2):21-25. PubMed ID: 31658186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-B*5801: a genetic susceptibility to allopurinol-induced DRESS.
    Mugwagwa AN; Fischer R; Zailan I
    Med J Aust; 2016 Mar; 204(4):159-60. PubMed ID: 26937673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.